News FDA to encourage approval of nicotine replacement therapies FDA commissioner wants to create new pathway
News European pharma calls for urgent Brexit medicines deal - but... ABPI and others concerned over potential disruption to supplies
News Catalyst to re-submit rare disease drug after trial success Already approved in EU, Catalyst aiming for FDA filing next year.
News FDA encourages cheap abuse-deterrent painkillers Regulator waiting for non-opioid alternatives to reach the market
Partner Content Partner Content The 10th Annual Social Media in Pharma – Exclusive Speaker I... Social Media in Pharma
News EMA's post-Brexit location to be decided today The location of the European Medicines Agency after Brexit is to be decided today, as representatives of member states vote in a complex secret ballot that could end with a coin toss.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
